126 related articles for article (PubMed ID: 22982481)
1. The nociceptin orphanin FQ peptide receptor agonist, Ro64-6198, impairs recognition memory formation through interaction with glutamatergic but not cholinergic receptor antagonists.
Reiss D; Prinssen EP; Wichmann J; Kieffer BL; Ouagazzal AM
Neurobiol Learn Mem; 2012 Oct; 98(3):254-60. PubMed ID: 22982481
[TBL] [Abstract][Full Text] [Related]
2. Activation of nociceptin opioid peptide (NOP) receptor impairs contextual fear learning in mice through glutamatergic mechanisms.
Goeldner C; Reiss D; Wichmann J; Kieffer BL; Ouagazzal AM
Neurobiol Learn Mem; 2009 May; 91(4):393-401. PubMed ID: 19100850
[TBL] [Abstract][Full Text] [Related]
3. Nociceptin receptor impairs recognition memory via interaction with NMDA receptor-dependent mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in the hippocampus.
Goeldner C; Reiss D; Wichmann J; Meziane H; Kieffer BL; Ouagazzal AM
J Neurosci; 2008 Feb; 28(9):2190-8. PubMed ID: 18305252
[TBL] [Abstract][Full Text] [Related]
4. Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine.
Reiss D; Wichmann J; Tekeshima H; Kieffer BL; Ouagazzal AM
Eur J Pharmacol; 2008 Jan; 579(1-3):141-8. PubMed ID: 18031727
[TBL] [Abstract][Full Text] [Related]
5. Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.
Ces A; Reiss D; Walter O; Wichmann J; Prinssen EP; Kieffer BL; Ouagazzal AM
Neuropsychopharmacology; 2012 Jan; 37(2):378-89. PubMed ID: 21881568
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198 in Chinese hamster ovary cells expressing recombinant human nociceptin receptors.
Hashiba E; Lambert DG; Jenck F; Wichmann J; Smith G
Life Sci; 2002 Mar; 70(15):1719-25. PubMed ID: 12002517
[TBL] [Abstract][Full Text] [Related]
7. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice.
Walentiny DM; Wiebelhaus JM; Beardsley PM
Drug Alcohol Depend; 2018 Jun; 187():335-342. PubMed ID: 29705547
[TBL] [Abstract][Full Text] [Related]
8. Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys.
Oliveira AWC; Pacheco JVN; Costa CS; Aquino J; Maior RS; Barros M
Pharmacol Biochem Behav; 2021 Dec; 211():173300. PubMed ID: 34798097
[TBL] [Abstract][Full Text] [Related]
9. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species.
Varty GB; Hyde LA; Hodgson RA; Lu SX; McCool MF; Kazdoba TM; Del Vecchio RA; Guthrie DH; Pond AJ; Grzelak ME; Xu X; Korfmacher WA; Tulshian D; Parker EM; Higgins GA
Psychopharmacology (Berl); 2005 Oct; 182(1):132-43. PubMed ID: 16025321
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area.
Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR
Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448
[TBL] [Abstract][Full Text] [Related]
12. Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation.
Rekik K; Faria Da Silva R; Colom M; Pacifico S; Zaveri NT; Calo' G; Rampon C; Frances B; Mouledous L
Neuropharmacology; 2017 Oct; 125():39-49. PubMed ID: 28705439
[TBL] [Abstract][Full Text] [Related]
13. Nociceptin/orphanin FQ reverses mecamylamine-induced learning and memory impairment as well as decrease in hippocampal acetylcholine release in the rat.
Hiramatsu M; Miwa M; Hashimoto K; Kawai S; Nomura N
Brain Res; 2008 Feb; 1195():96-103. PubMed ID: 18191820
[TBL] [Abstract][Full Text] [Related]
14. NMDA antagonists potentiate scopolamine-induced amnesic effect.
Li HB; Matsumoto K; Tohda M; Yamamoto M; Watanabe H
Behav Brain Res; 1997 Feb; 83(1-2):225-8. PubMed ID: 9062690
[TBL] [Abstract][Full Text] [Related]
15. Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat.
Obara I; Przewlocki R; Przewlocka B
Pain; 2005 Jul; 116(1-2):17-25. PubMed ID: 15927383
[TBL] [Abstract][Full Text] [Related]
16. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
Ko MC; Woods JH; Fantegrossi WE; Galuska CM; Wichmann J; Prinssen EP
Neuropsychopharmacology; 2009 Aug; 34(9):2088-96. PubMed ID: 19279568
[TBL] [Abstract][Full Text] [Related]
17. Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats.
Rutten K; De Vry J; Bruckmann W; Tzschentke TM
Eur J Pharmacol; 2010 Oct; 645(1-3):119-26. PubMed ID: 20674566
[TBL] [Abstract][Full Text] [Related]
18. Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function.
Higgins GA; Grottick AJ; Ballard TM; Richards JG; Messer J; Takeshima H; Pauly-Evers M; Jenck F; Adam G; Wichmann J
Neuropharmacology; 2001 Jul; 41(1):97-107. PubMed ID: 11445190
[TBL] [Abstract][Full Text] [Related]
19. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
20. Cerebral cortical muscarinic cholinergic and N-methyl-D-aspartate receptors mediate increase in cortical blood flow elicited by chemical stimulation of periaqueductal gray matter.
Nakai M; Maeda M
Neuroscience; 2000; 98(3):449-57. PubMed ID: 10869839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
